2020 National Conference Program 

Check out our list of confirmed speakers!

Wall Street’s Outlook on the PBM Industry
George Hill, Managing Director, Equity Research Analyst, Deutsche Bank Securities

Exploring PBM Models: The Truth Behind Transparency
Arlene Edlin, General Manager, Sales, Navitus Health Solutions

Data Dump: Using Data Science and Visual Analytics to identify industry trends and drive clinical innovation
Ryan J. Atkinson, PharmD, MBA, Senior Director, Specialty Pharmacy Strategy, Maxor National Pharmacy Services
Michael T. Einodshofer, RPh, MBA, Chief Pharmacy Officer, Maxor National Pharmacy Services, LLC

Genes Matter – The Value of Pharmacogenetic Testing in Pharmacy Benefits
Sonja Quale, PharmD, Chief Clinical Officer, Confidio, LLC
Joel Diamond, MD, CMO, 2bPreciseHealth

Pay for Performance: A New PBM Model That’s Revolutionizing the Industry
Hugh Gallagher, PharmD, Vice President, Business Development, BeneCard PBF

The U.S. Pharmaceutical Market: Trends, Issues, and Outlook
Doug Long, Vice President Industry Relations, IQVIA

The 25 Year PBM Shift: How PBM’s Have Managed Drug Trend …Then & Now
Patty Taddei-Allen, PharmD, MBA, Senior Director, Clinical Analytics, Research, WellDyneRx
Nick Page, PharmD, Chief Pharmacy Officer, WellDyneRx

Radical Transparency: See What Can Happen When Integrated Data Is Leveraged to Address High-Cost Conditions, Control Drug Spend and Promote a Better Member Experience
Karen Coderre, Director of Clinical and Quality Management, Blue Cross Blue Shield North Carolina
Libby Johnson, Senior Vice President, Client Success, Pharmaceutical Strategies Group

How Will Blockchain Technology Disrupt the PBM-Payer-Pharmacy Relationship?
Gregory O. Callahan, MBA, Consultant, Milliman
Brian N. Anderson, MBA, Principal, Milliman
Panel TBD

Best Practices for Effective Specialty Pharmacy Management
Ross Hoffman, MD, Chief Medical Officer, Envolve Pharmacy Solutions

New Paradigm in Pharmacy Benefit Management
Mona Hamood, Director of Pharmacy, EHIM, Inc.
Kenneth Aldridge, MS HSA, Director of Health Services, Rosen Medical Center

PBM Contracting in a Sea of Uncertainty: Obtaining the PBM Contract You Want at a Competitive Price Without Months of Negotiations
Rachel A. Alexander, JD, Attorney at Law, Partner, Wiley Rein, LLP
Dot Powell-Woodson, Attorney at Law, Partner, Wiley Rein, LLP
Beth Hebert-Silvia, Senior Vice President & Practice Lead, Health Plans, Pharmaceutical Strategies Group
Zack Jacobson, Consulting, MCO, Pharmaceutical Strategies Group

Finding Bad Actors: Combatting Drug Fraud, Waste and Abuse Is More Than A “One Act Play”
Jo-Ellen Abou Nader, CFE, CIA, CRMA, Vice President of Fraud, Waste, and Abuse and Supply Chain Optimization, Prime Therapeutics

Identifying At-Risk Members for Chronic Conditions and Helping Them Navigate Care and Comorbidities
Pete Simmons, Vice President, Complex Disease Optim Transformation, CVS Health

Delivering Documented Savings Through Drug Cost Transparency at the Point-of -Care
Matt Nye PharmD, Vice President, Pharmacy Blue Shield of CA- Retired
Edward Fotsch, MD, CEO,Gemini Health LLC

Highlights from the Last 12 Months in Value-Based Drug Pricing and What’s Next
Steven D. Pearson, MD, MSc, President, Institute for Clinical Economic Review (ICER)

What’s Trending in Pharmacy: 2020 and Beyond
David Calabrese, RPh, MHP, Senior Vice President & Chief Pharmacy Officer, OptumRx

A Journey of an Oncology Specialty Pharmacy Patient through the Lens of the Patient, Physician, PBM and Specialty Pharmacy
Jennifer Mellum, MBA, Senior Director, Customer Experience & Insights, Prime Therapeutics
Rick Miller, MS, MBA, RPh, CSP, Vice President, Clinical and Professional Services, AllianceRx Walgreens Prime
Seth Berkowitz, Senior Director of Patient and Community Outreach, Leukemia and Lymphoma Society (LLS)
Co-Presenter TBD

The Future of Health Care: Simple, Affordable, Predictable
Steve Miller, MD, Chief Clinical Officer, Cigna

Employer Focused Purchaser Assessment Tool for Value Based Healthcare
F. Randy Vogenberg, PhD, FASHP, Board Chair, Employer Provider Interface Council of the Hospital Quality Foundation
Richard H. Bullard, RPh, Advisor-Fellow, Employer-Provider Interface Council of the Hospital Quality Foundation

From Information to Action: How Prescribers are Using Benefit Optimization Tools to Make the Best Care Decisions
Michelle Trombetta, Director, Product Innovation, Surescripts
John Mark Reimann, MBA, Product Development Director, Prime Therapeutics

Use of Integrated Data and Total Cost of Care in the Management of Multiple Sclerosis 
Tiffany Sarell, PharmD, Senior Clinical Consultant, Pharmaceutical Strategies Group
Jeremy Weidner, Associate Data Scientist, Pharmaceutical Strategies Group

Optimizing Manufacturer Copay Cards and HCPCS Payment Limits to Reduce Plan Spend
Jeffrey Schmitt, PharmD, Director of Pharmacy Benefits, Cleveland Clinic

PBM Pricing Models: Caps, Traps, and Delivering Value to Plan Sponsors
Alan Pannier, PharmD, MBA, Head of Clinical Services, SmithRx
Sydni Meyrowitz, Head of Strategy and Operations, SmithRx

How Consumer Solutions Designed to Offer Convenient, In-Home Care Can Drive Better Health
Yasmin Samra, PharmD, Staff VP Pharmacy Product Strategy Development, IngenioRx

Cancer Navigation Program: Partnering with Employers to Provide Compassionate, Effective Support
Karen van Caulil, PhD, President and CEO, Florida Alliance for Healthcare Value
Beth A. Curran, Senior Director, Risk Management, Orange County Public Schools
Erica L. Thomas, Director, Client Operations, The Center for Living Well, Premise Health

The Employer’s Risk Exposure to Prescription Drug Cost under Medical Specific Stop Loss Insurance
Crystal Williams, President, RxReins